Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Operating Expenses | 45,261 | 23,462 | 15,749 | 9,649 | 0 |
| Operating Income | -45,261 | -23,462 | -15,749 | -9,649 | N/A |
| Other Income | 174 | 166 | 24 | 0 | 0 |
| Pre-tax Income | -45,087 | -23,296 | -15,725 | -9,649 | 0 |
| Net Income Continuous | -45,087 | -23,296 | -15,725 | -9,649 | N/A |
| Net Income | $-45,087 | $-23,296 | $-15,725 | $-9,649 | $N/A |
| EPS Basic Total Ops | -325.39 | -582.79 | -6,154.93 | -5,033.06 | N/A |
| EPS Basic Continuous Ops | -324.63 | -582.98 | -6,119.40 | -5,022.65 | N/A |
| EPS Diluted Total Ops | -325.39 | -582.79 | -6,154.93 | -5,033.06 | N/A |
| EPS Diluted Continuous Ops | -324.63 | -582.98 | -6,119.40 | -5,022.65 | N/A |
| EBITDA(a) | $-45,080 | $-23,441 | $-15,739 | $-9,640 | $N/A |